REGULATORY COMPLIANCE

Monitoring for compliance with electronic records and electronic signatures starts with recognizing disruptions or failures during day-to-day operations in both manufacturing and laboratory environments. Symptoms of potential non-compliance can manifest…

Comprehensive Guide to Ensuring Compliance with ERES for GMP Computerized Systems In the realm of pharmaceutical manufacturing, compliance with regulatory requirements concerning electronic records and electronic signatures (ERES) is paramount.…

In the realm of pharmaceutical manufacturing, symptoms related to electronic signatures can manifest as:Click to read the full article.

In the initial phase of our scenario, workers on the manufacturing floor reported discrepancies in batch records. Several personnel observed that entries were missing or seemed altered without appropriate audit…

The first step in addressing compliance with 21 CFR Part 11 is recognizing the symptoms that suggest a potential lapse in adherence to regulatory expectations. Common signals include:Click to read…

Errors surrounding electronic records and electronic signatures can manifest through various indicators. Recognizing these symptoms early is crucial for timely intervention. Common signals include:Click to read the full article.

Creating Effective Audit Trails for Electronic Record Integrity The integrity of electronic records is a common concern in pharmaceutical manufacturing and quality assurance. As companies transition to digital solutions, the…

Identifying symptoms associated with electronic signatures and records is crucial for early intervention. Common signals include:Click to read the full article.

During a routine FDA inspection of a sterile manufacturing facility, the inspectors noted several discrepancies in the electronic records system used for batch production documentation. Key symptoms observed included:Click to…